Azelnidipine and amlodipine: a comparison of their pharmacokinetics and effects on ambulatory blood pressure.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Hypertension Research

• Publication date

  2003-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1291/HYPRES.26.201PMID 12675275
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Differential effects of a long-acting angiotensin converting enzyme inhibitor (temocapril) and a long-acting calcium antagonist (amlodipine) on ventricular ectopic beats in older hypertensive patients.

  2002cited by this paper
• Questionnaire survey on the Japanese guidelines for treatment of hypertension in the elderly: 1999 revised version.

  2002cited by this paper
• Guidelines for the management of hypertension for general practitioners.

  2001cited by this paper
• Stroke Prognosis and Abnormal Nocturnal Blood Pressure Falls in Older Hypertensives

  2001cited by this paper
• Cardiovascular protection and blood pressure reduction: a meta-analysis.

  2001cited by this paper
• Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT).

  2000cited by this paper
• Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study.

  2000cited by this paper
• Health outcomes associated with calcium antagonists compared with other first-line antihypertensive therapies: a meta-analysis of randomised controlled trials.

  2000cited by this paper
• Effects of cilnidipine, a novel dihydropyridine calcium antagonist, on autonomic function, ambulatory blood pressure and heart rate in patients with essential hypertension.

  2000cited by this paper
• Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration.

  2000cited by this paper
• RANDOMIZED DOUBLE-BLIND COMPARISON OF A CALCIUM CHANNEL BLOCKER AND A DIURETIC IN ELDERLY HYPERTENSIVES : A FINAL RESULT OF THE NATIONAL INTERVENTIONAL COOPERATIVE STUDY IN ELDERLY HYPERTENSION (NICS-EH)

  2000cited by this paper
• Long-term effects of CS-905 (azelnidipine) on diurnal blood pressure variation and hemodynamics in patients with essential hypertension

  2000cited by this paper
• Pharmacokinetic study of CS-905 (azelnidipine) in elderly patients with essential hypertension

  2000cited by this paper
• Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study.

  1999cited by this paper
• Prolonged antihypertensive effect of amlodipine: a prospective double-blind randomized study.

  1999cited by this paper
• Randomized double-blind comparison of a calcium antagonist and a diuretic in elderly hypertensives. National Intervention Cooperative Study in Elderly Hypertensives Study Group.

  1999cited by this paper
• Effects of amlodipine and cilnidipine on cardiac sympathetic nervous system and neurohormonal status in essential hypertension.

  1999cited by this paper
• Selectivities of dihydropyridine derivatives in blocking Ca(2+) channel subtypes expressed in Xenopus oocytes.

  1999cited by this paper
• Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension

  1998cited by this paper
• Cloning and characterization of alpha1H from human heart, a member of the T-type Ca2+ channel gene family.

  1998cited by this paper
• Comparison of the efficacy of dihydropyridine calcium channel blockers in African American patients with hypertension. ISHIB Investigators Group. International Society on Hypertension in Blacks.

  1998cited by this paper
• Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension *

  1997cited by this paper
• Effect of long-acting and short-acting calcium antagonists on cardiovascular outcomes in hypertensive patients.

  1997cited by this paper
• Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

  1997cited by this paper
• Shanghai trial of nifedipine in the elderly (STONE).

  1996cited by this paper
• Azelnidipine (CS‐905), A Novel Dihydropyridine Calcium Channel Blocker with Gradual Onset and Prolonged Duration of Action

  1995cited by this paper
• Molecular determinants of Ca2+ channel function and drug action.

  1995cited by this paper
• Nifedipine. Dose-related increase in mortality in patients with coronary heart disease.

  1995cited by this paper
• The risk of myocardial infarction associated with antihypertensive drug therapies.

  1995cited by this paper
• The use of self-measured blood pressure determinations in assessing dynamics of drug compliance in a study with amlodipine once a day, morning versus evening

  1993cited by this paper
• Antihypertensive effects of CS-905, a novel dihydropyridine Ca++ channel blocker.

  1989cited by this paper
• Pharmacologic profile of amlodipine.

  1989cited by this paper

• Multicomponent Synthesis of Spiro‐Annulated 1,4‐Dihydropyridines from Pyrrole‐2,3‐diones, Malononitrile, and Enamines

  2025cites this paper
• Efficacy and safety of Azelnidipine-Telmisartan vs. Amlodipine-Telmisartan: a prospective randomized trial in Indian hypertensive patients.

  2025cites this paper
• Effects of vasodilators on beat-to-beat and every fifteen minutes blood pressure variability induced by noradrenaline infusion in rats

  2024cites this paper
• Azelnidipine protects HL-1 cardiomyocytes from hypoxia/reoxygenation injury by enhancement of NO production independently of effects on gene expression

  2024influential citation
• Efficacy and Safety of Azelnidipine as an Antihypertensive Compared to Amlodipine: A Systematic Review and Meta-analysis

  2023cites this paper
• The Effect of Antihypertensive Drugs on NADH in Newly Diagnosed Primary Hypertension

  2022cites this paper
• Therapeutic Usefulness of a Novel Calcium Channel Blocker Azelnidipine in the Treatment of Hypertension: A Narrative Review

  2022influential citation
• Azelnidipine treatment reduces the expression of Cav1.2 protein.

  2021cites this paper
• Palladium‐Catalyzed Regioselective and Stereospecific Ring‐Opening Suzuki‐Miyaura Arylative Cross‐Coupling of 2‐Arylazetidines with Arylboronic Acids

  2021cites this paper
• A case of complete atrioventricular block with extremely high blood concentration of azelnidipine

  2021influential citation
• Revisited: Therapeutic and toxic blood concentrations of more than 1100 drugs and other xenobiotics

  2020cites this paper
• Plasma Trough Concentrations of Antihypertensive Drugs for the Assessment of Treatment Adherence

  2020cites this paper
• Acute idiopathic polyradiculoneuritis with secondary arterial hypertension in a 5-year-old male Siberian Husky

  2020cites this paper
• Independent and interactive associations of heart rate and body mass index or blood pressure with type 2 diabetes mellitus incidence: A prospective cohort study

  2019cites this paper
• The angiotensin II type 1 receptor blocker azilsartan can overwhelm the sympathetic nerve activation stimulated by coadministration of calcium channel blockers

  2019cites this paper
• Efficacy and safety of a combination antihypertensive drug (olmesartan plus azelnidipine): “Issues with hypertension studies in real-world practice”

  2019influential citation
• Limonin alleviates macro- and micro-vascular complications of metabolic syndrome in rats: A comparative study with azelnidipine.

  2018cites this paper
• Azelnidipine Attenuates the Oxidative and NFκB Pathways in Amyloid-β-Stimulated Cerebral Endothelial Cells.

  2018cites this paper
• The effects of azelnidipine and amlodipine in treatment of mild to moderate hypertension : a systematic review

  2017influential citation
• Efficacy and tolerability of initial high vs low doses of S‐(‐)‐amlodipine in hypertension

  2017cites this paper
• Comparison of the effects of L-type calcium channel antagonist Amlodipine with L/N-type calcium channel antagonist Cilnidipine on blood pressure, heart rate, proteinuria and lipid profile in hypertensive patients

  2016cites this paper
• Investigational calcium channel blockers for the treatment of hypertension

  2016cites this paper
• Estudo da associação do treinamento físico aeróbio com diferentes terapias farmacológicas sobre as adaptações autonômicas cardíacas em ratos espontaneamente hipertensos (SHR)

  2016cites this paper
• Effects of azelnidipine and amlodipine on exercise-induced sympathoexcitation assessed by pupillometry in hypertensive patients

  2016cites this paper
• L/T-type calcium channel blocker reduces non-Gaussianity of heart rate variability in chronic kidney disease patients under preceding treatment with ARB

  2016cites this paper
• A clinical study of the effects of cilnidipine and amlodipine in hypertensive patient focusing on pedal edema

  2016cites this paper
• Cilnidipine but not amlodipine suppresses sympathetic activation elicited by isometric exercise in hypertensive patients

  2015cites this paper
• Resting heart rate and the risk of developing impaired fasting glucose and diabetes: the Kailuan prospective study.

  2015cites this paper
• Cardio-ankle vascular index (CAVI) differentiates pharmacological properties of vasodilators nicardipine and nitroglycerin in anesthetized rabbits.

  2015cites this paper
• Azelnidipine and glucose tolerance: possible indications and treatment selection for hypertensive patients with metabolic disorders

  2015cites this paper
• Comparison of Azelnidipine and Trichlormethiazide in Japanese Type 2 Diabetic Patients with Hypertension: The COAT Randomized Controlled Trial

  2015cites this paper
• Negligible Pharmacokinetic Interaction of Red Ginseng and Antihypertensive Agent Amlodipine in Sprague-Dawley Rats

  2014cites this paper
• Hypertension Potential Clinical Application of Recently Discovered Brain Mechanisms Involved in

  2014cites this paper
• Effects of azelnidipine on uric acid metabolism in patients with essential hypertension

  2014cites this paper
• Effects of Combination Therapy With Olmesartan and Azelnidipine on Serum Osteoprotegerin in Patients With Hypertension

  2014cites this paper
• Azelnidipine, Not Amlodipine, Induces Secretion of Vascular Endothelial Growth Factor From Smooth Muscle Cells and Promotes Endothelial Tube Formation

  2014cites this paper
• Vasorelaxation induced by new third-generation dihydropyridine calcium antagonist azelnidipine in human internal mammary artery.

  2013cites this paper
• Kidney-protective effects of azelnidipine versus a diuretic in combination with olmesartan in hypertensive patients with diabetes and albuminuria: a randomized study.

  2013cites this paper
• Renal Microcirculation and Calcium Channel Subtypes

  2013cites this paper
• Potential Clinical Application of Recently Discovered Brain Mechanisms Involved in Hypertension

  2013cites this paper
• Enhanced Blood Pressure–Lowering Effect of Olmesartan in Hypertensive Patients With Chronic Kidney Disease–Associated Sympathetic Hyperactivity: HONEST Study

  2013cites this paper
• Effect of azelnidipine and amlodipine on single cell mechanics in mouse cardiomyocytes.

  2013cites this paper
• Inhibitory Effects of Azelnidipine Tablets on Morning Hypertension

  2013cites this paper
• Anti-atherogenic effects of the combination therapy with olmesartan and azelnidipine in diabetic apolipoprotein E-deficient mice.

  2012cites this paper
• Azelnidipine

  2012cites this paper
• Azelnidipine

  2012cites this paper
• The combination of OLmesartan and a CAlcium channel blocker (azelnidipine) or candesartan and a calcium channel blocker (amlodipine) in type 2 diabetic hypertensive patients: The OLCA study

  2012cites this paper
• Azelnidipine is a calcium blocker that attenuates liver fibrosis and may increase antioxidant defence

  2012cites this paper
• Impact of Increased Heart Rate on Clinical Outcomes in Hypertension

  2012cites this paper
• Angiotensin II receptor blocker-based therapy in Japanese elderly, high-risk, hypertensive patients.

  2012cites this paper
• Mechanistic study on degradation of azelnidipine solution under radical initiator-based oxidative conditions.

  2012cites this paper
• The Pharmacological Differences in Antianginal Effects of Long-lasting Calcium Channel Blockers: Azelnidipine and Amlodipine

  2012cites this paper
• Comparison of effects of azelnidipine and trichlormethiazide in combination with olmesartan on blood pressure and metabolic parameters in hypertensive type 2 diabetic patients

  2011cites this paper
• Comparative effects of azelnidipine and amlodipine on myocardial function and mortality after ischemia/reperfusion in dogs.

  2011cites this paper
• Continuous hypertension and tachycardia after resection of a hemangioblastoma behind the dorsal medulla oblongata: relationship to sympathetic overactivity at the neurogenic vasomotor center

  2010cites this paper
• Effects of combination olmesartan medoxomil plus azelnidipine versus monotherapy with either agent on 24-hour ambulatory blood pressure and pulse rate in Japanese patients with essential hypertension: additional results from the REZALT study.

  2010cites this paper
• Azelnidipine, a long-acting calcium channel blocker, could control hypertension without decreasing cerebral blood flow in post-ischemic stroke patients. A 123I-IMP SPECT follow-up study

  2010cites this paper
• A New Baroreceptor Sensitivity-Restoring Ca-Channel Blocker Diminishes Age-Related Morning Blood Pressure Increase in Hypertensive Patients: Open-Label Monitoring of Azelnidipine Treatment for Hypertension in the Early Morning (At-HOME) Study

  2010cites this paper
• Cytokine reducing effect of azelnidipine in human peripheral blood mononuclear cells.

  2010cites this paper
• Continuous hypertension and tachycardia after resection of a hemangioblastoma behind the dorsal medulla oblongata: relationship to sympathetic overactivity at the neurogenic vasomotor center.

  2010cites this paper
• Cardiovascular effects of azelnidipine in comparison with those of amlodipine assessed in the halothane-anaesthetized dog.

  2010cites this paper
• Azelnidipine and Amlodipine: A Comparison of Their Effects and Safety in a Randomized Double-Blinded Clinical Trial in Chinese Essential Hypertensive Patients

  2010cites this paper
• Rationale, design and patient baseline characteristics of OlmeSartan and calcium antagonists randomized (OSCAR) study: a study comparing the incidence of cardiovascular events between high-dose angiotensin II receptor blocker (ARB) monotherapy and combination therapy of ARB with calcium channel bloc

  2009cites this paper
• Higher heart rate may predispose to obesity and diabetes mellitus: 20-year prospective study in a general population.

  2009cites this paper
• CPU0213, A NON‐SELECTIVE ETA/ETB RECEPTOR ANTAGONIST, IMPROVES PULMONARY ARTERIOLAR REMODELING OF MONOCROTALINE‐INDUCED PULMONARY HYPERTENSION IN RATS

  2009influential citation
• A randomized, double-blind, four-arm parallel-group study of the efficacy and safety of azelnidipine and olmesartan medoxomil combination therapy compared with each monotherapy in Japanese patients with essential hypertension: the REZALT study

  2009cites this paper
• Chronotropic Effects of Azelnidipine, a Slow- and Long-acting Dihydropyridine-type Calcium Channel Blocker, in Anesthetized Dogs: A Comparison With Amlodipine

  2009cites this paper
• Association between peritoneal dialysate effluent leukocytosis and amlodipine besylate.

  2009cites this paper
• Differential Effects Between a Calcium Channel Blocker and a Diuretic When Used in Combination With Angiotensin II Receptor Blocker on Central Aortic Pressure in Hypertensive Patients

  2009cites this paper
• Prevention of vascular injury by combination of an AT1 receptor blocker, olmesartan, with various calcium antagonists.

  2009cites this paper
• Cilnidipine: a new generation Ca channel blocker with inhibitory action on sympathetic neurotransmitter release.

  2009cites this paper
• Interactions between grapefruit juice and calcium channel antagonists.

  2009cites this paper
• Comparative pharmacodynamics of olmesartan and azelnidipine in patients with hypertension: a population pharmacokinetic/pharmacodynamic analysis.

  2009cites this paper
• Spectroscopic studies on the interaction of azelnidipine with bovine serum albumin.

  2008cites this paper
• Cost-Utility Analysis of Antihypertensive Combination Therapy in Japan by a Monte Carlo Simulation Model

  2008cites this paper
• Effects of Strict Blood Pressure Control by a Long-Acting Calcium Channel Blocker on Brain Natriuretic Peptide and Urinary Albumin Excretion Rate in Japanese Hypertensive Patients

  2008cites this paper
• Effects of azelnidipine on the autonomic functions and its influence on arterial stiffness and endothelial functions.

  2008cites this paper
• In Half of Hypertensive Diabetics, Co-Administration of a Calcium Channel Blocker and an Angiotensin-Converting Enzyme Inhibitor Achieved a Target Blood Pressure of <130/80 mmHg: The Azelnidipine and Temocapril in Hypertensive Patients with Type 2 Diabetes (ATTEST) Study

  2008cites this paper
• Azelnidipine has anti-atherosclerotic effects independent of its blood pressure-lowering actions in monkeys and mice.

  2008cites this paper
• Determination of azelnidipine by LC-ESI-MS and its application to a pharmacokinetic study in healthy Chinese volunteers.

  2008cites this paper
• Clinical Study with Azelnidipine in Patients with Essential Hypertension

  2007cites this paper
• Azelnidipine Attenuates Cardiovascular and Sympathetic Responses to Air-Jet Stress in Genetically Hypertensive Rats

  2007cites this paper
• Long-Acting Calcium Channel Blocker, Azelnidipine, Increases Endothelial Nitric Oxide Synthase in the Brain and Inhibits Sympathetic Nerve Activity

  2007cites this paper
• Effects of New Calcium Channel Blocker, Azelnidipine, and Amlodipine on Baroreflex Sensitivity and Ambulatory Blood Pressure

  2007cites this paper
• Effect of benidipine on simvastatin metabolism in human liver microsomes.

  2007cites this paper
• Prevention of neuronal damage by calcium channel blockers with antioxidative effects after transient focal ischemia in rats.

  2007cites this paper
• Note EŠect of Benidipine on Simvastatin Metabolism in Human Liver Microsomes

  2007cites this paper
• Determination of azelnidipine in human plasma by liquid chromatography-electrospray ionization-mass spectrometry.

  2007cites this paper
• The actions of azelnidipine, a dihydropyridine‐derivative Ca antagonist, on voltage‐dependent Ba2+ currents in guinea‐pig vascular smooth muscle

  2006cites this paper
• Tilting-Induced Decrease in Systolic Blood Pressure in Bedridden Hypertensive Elderly Inpatients: Effects of Azelnidipine

  2006cites this paper
• Enhancement of cardiac oxidative stress by tachycardia and its critical role in cardiac hypertrophy and fibrosis

  2006cites this paper
• Efficacy of Azelnidipine on Home Blood Pressure and Pulse Rate in Patients with Essential Hypertension: Comparison with Amlodipine

  2006cites this paper
• Azelnidipine, a New Long-acting Calcium-channel Blocker, Inhibits Tumour Necrosis Factor-α-induced Monocyte Chemoattractant Protein-1 Expression in Endothelial Cells

  2006cites this paper
• A third-generation, long-acting, dihydropyridine calcium antagonist, azelnidipine, attenuates stent-associated neointimal formation in non-human primates

  2006cites this paper
• Japanese Society of Hypertension

  2006cites this paper
• Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2004).

  2006cites this paper
• New Generation Calcium Channel Blockers in Hypertensive Treatment.

  2006cites this paper
• Polymyositis Initiation Involving Amlodipine Besylate

  2006cites this paper
• Effect of a Single Glass of Grapefruit Juice on the Apparent Oral Bioavailability of the Dihydropyridine Calcium Channel Antagonist, Azelnidipine, in Healthy Japanese Volunteers

  2006cites this paper
• Azelnidipine down-regulates renal angiotensin-converting enzyme and mineralocorticoid receptor mRNA in diabetic hypertensive rats.

  2006cites this paper